Skip to content
Catalyst

PapersPMID:39754214

Effect of Astragalus injection treatment for viral myocarditis: a systematic review and meta-analysis.

European journal of medical research2025The record ↗

  1. Finding, moderate evidencelowersAspartate aminotransferase

What moved

1 findingHow to read these marks →
  • Decreases aspartate aminotransferase

    moderate

    “The Astragalus injection group demonstrated a significantly lower ∆AST [WMD = − 14.23, 95%CI (− 24.17, − 4.30)] compared to the control group, with a statistically significant difference (P < 0.05).”
    Study
    meta-analysis
    Effect
    −14.23 mean difference, 95% CI −24.17 to −4.3
    Dose studied
    Pooled; Astragalus injection about 10 to 60 mL per day, or per kg body weight in some trials, once daily in most
    Population
    Patients with viral myocarditis; pooled randomised trials in which both arms received conventional treatment and only the experimental arm also received Astragalus injection

Study record

Design
meta-analysis
Species
human
Population
Adult patients clinically diagnosed with viral myocarditis in 26 RCTs, all receiving conventional treatment
Participants
2,793
Comparator
no treatment
Duration
not reported
Endpoints measured
21